Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate CancerPhillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
Molecular Cancer Research : MCR|February 18, 2018
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic SignatureUdit Singhal, Yugang Wang, James Henderson, et al.
JU Open Plus|February 19, 2026
Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate CancerNicholas W Eyrich, Yijian Huang, Yingye Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Cancer Research|September 5, 2006
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerSven Perner, Francesca Demichelis, Rameen Beroukhim, et al.
Cancer Research|October 17, 2015
ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic MechanismsPhillip L Palmbos, Lidong Wang, Huibin Yang, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
Hypertension (Dallas, Tex. : 1979)|February 12, 2019
Genetic Characteristics of Aldosterone-Producing Adenomas in BlacksKazutaka Nanba, Kei Omata, Celso E Gomez-Sanchez, et al.
The Journal of Biological Chemistry|May 7, 2020
The role of the histone H3 variant CENPA in prostate cancerAnjan K Saha, Rafael Contreras-Galindo, Yashar S Niknafs, et al.
Pageof 24